News

As part of the acquisition, Bayer now owns Merck’s existing over-the-counter (OTC) business, including the global trademark and prescription rights for Claritin and Afrin. Bayer has held back

Vedolizumab is a gut-selective humanized monoclonal antibody that has recently been made available in the US and the EU, and also approved in Australia under the trade name

Bioceltran is focused on Protein Transduction Domain (PTD) Technology for transdermal delivery of drugs for cosmetics and pharmaceuticals. Following the signing the license deal, Quest purchased 38% ownership

The patient who arrived from Liberia, West Africa on 20 September sought for medical care at Texas Health Presbyterian Hospital of Dallas on 24 of the same month.

Under the deal, Fast Forward will provide funding to Glialogix for preclinical studies of GLX1112, a first-in-class neuroprotective therapy designed to slow the accumulation of disability in progressive

The new indication of XTANDI, an oral, once-daily androgen receptor inhibitor capsule, is for treatment of CRPC patients who have not received chemotherapy. XTANDI is currently available for

The expansion significantly increases plasma processing and albumin production capacity in the Kankakee, Ill. facility. The new facility will use the same state-of-the-art technology as CSL Behring’s long-standing

AG’s IP is comprised of T Cells Receptor ("TCR") clonality analysis technology and T Central Memory Cell ("Tcm") and Dendritic Cell ("DC") preparation methodologies. The TCR clonality analysis

The issued patent # 8,846,635 is titled, "Method for inducing hepatocyte proliferation and uses thereof." Can-Fite has recently been granted a patent for this technology in Japan and